- Home
- IMOS vs PSNL Comparison
IMOS vs PSNL Comparison
Compare IMOS & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- PSNL
- Stock Information
- Founded
- IMOS 1997
- PSNL 2011
- Country
- IMOS Taiwan
- PSNL United States
- Employees
- IMOS N/A
- PSNL 229
- Industry
- IMOS Semiconductors
- PSNL Medical Specialities
- Sector
- IMOS Technology
- PSNL Health Care
- Exchange
- IMOS Nasdaq
- PSNL Nasdaq
- Market Cap
- IMOS 668.5M
- PSNL 580.3M
- IPO Year
- IMOS N/A
- PSNL 2019
- Fundamental
- Price
- IMOS $18.72
- PSNL $7.04
- Analyst Decision
- IMOS
- PSNL Strong Buy
- Analyst Count
- IMOS 0
- PSNL 5
- Target Price
- IMOS N/A
- PSNL $8.00
- AVG Volume (30 Days)
- IMOS 25.0K
- PSNL 1.7M
- Earning Date
- IMOS 08-12-2025
- PSNL 08-06-2025
- Dividend Yield
- IMOS 3.43%
- PSNL N/A
- EPS Growth
- IMOS N/A
- PSNL N/A
- EPS
- IMOS 0.05
- PSNL N/A
- Revenue
- IMOS $685,506,006.00
- PSNL $85,694,000.00
- Revenue This Year
- IMOS N/A
- PSNL $0.45
- Revenue Next Year
- IMOS $2.21
- PSNL $25.75
- P/E Ratio
- IMOS $18.94
- PSNL N/A
- Revenue Growth
- IMOS 2.89
- PSNL 15.57
- 52 Week Low
- IMOS $12.78
- PSNL $1.41
- 52 Week High
- IMOS $26.91
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- IMOS 48.36
- PSNL 63.03
- Support Level
- IMOS $18.02
- PSNL $6.52
- Resistance Level
- IMOS $19.20
- PSNL $7.79
- Average True Range (ATR)
- IMOS 0.60
- PSNL 0.50
- MACD
- IMOS -0.11
- PSNL 0.00
- Stochastic Oscillator
- IMOS 35.66
- PSNL 56.14
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.